As deregulation of UCH-L1 level can lead to Alzheimer’s disease [19] and some types of cancer [20], UCH-L1 is frequently used in research as a drug target [21]. This evidence concerns the gene UCHL1 and early-onset autosomal dominant Alzheimer disease.